cgxd_8k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (date of earliest event reported): December 1, 2009
CHINA XD PLASTICS COMPANY
LIMITED
(Exact
name of registrant as specified in charter)
Nevada
(State or
other jurisdiction of incorporation)
333-134073
(Commission
File Number)
|
04-3836208
(IRS
Employer Identification No.)
|
No. 9
Qinling Road, Yingbin Road Centralized Industrial Park
Harbin
Development Zone, Heilongjiang, China 150078
(Address
of principal executive offices and zip code)
86-451-84346600
(Registrant’s
telephone number including area code)
(Former
Name and Former Address)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR
240.14a-12(b))
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 3.02 Unregistered Sales
of Equity Securities
On
December 1, 2009, the Registrant consummated a private placement of 15,188
shares of Series C Convertible Preferred Stock, par value $0.001 per share (the
“Series C Preferred
Stock”) at a purchase price of $1,000 per share, and two series of
warrants, Series A Warrants and Series B Warrants (collectively, the “Warrants”), for gross
proceeds of approximately $15.2 million (the “Financing”). with
several institutional and individual investors. Rodman & Renshaw,
LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc.
(Nasdaq: RODM),
acted as the exclusive placement agent for the transaction. The
Series C Preferred Stock and Warrants were sold in a transaction not involving a
public offering and were issued without registration in reliance upon the
exemption from registration afforded by Section 4(2) of the Securities Act of
1933, as amended and Regulation D promulgated thereunder.
Terms
of Conversion of the Series C Preferred Stock
The
Series C Preferred Stock is convertible into the Company’s common stock, par
value $0.001 per share (the “Common Stock”), at a
conversion price of $4.60 per share and will accrue cumulative dividends at the
rate of 6% per annum until maturity on December 1, 2012. If the
Series C Preferred Stock is converted prior to maturity, the Company will pay
the holder an amount equal to the total dividend that would accrue on the Series
C Preferred Stock from the Closing Date through maturity, less any dividend
payments already made with respect to the converted Series C Preferred
Stock.
Terms
of Exercise of the Series A Warrant
The
Series A Warrants are exercisable into 1,320,696 shares of Common Stock at an
exercise price of $5.50 per share. The Series A Warrant will be
initially exercisable six months after the closing of the transaction, and have
a term of five years. The Series A Warrants contain anti-dilution
protection provisions which, in addition to adjustments for customary corporate
events, such as the subdivision or combination of the Company’s shares of Common
Stock, provide for an adjustment in the exercise price if the Company issues
additional shares of its Common Stock or securities convertible or exchangeable
for Common Stock at a purchase price per share less than $5.50. The exercise
price would be reduced to such purchase price, but in no event would it be less
than $4.40.
Terms
of Exercise of Series B Warrant
The
Series B Warrants are exchangeable for a maximum of 1,178,722 shares of Common
Stock at an exercise price of $0.0001 per share. The Series B
Warrants automatically become exercisable into shares of Common Stock on the
date (the “First Date
of Determination”) that is six trading days after the earlier of the date
that the shares of Common Stock underlying the Series C Preferred Stock and the
Warrants are initially registered under an effective resale registration
statement (the “Effective Date”) or
the six month anniversary of the Closing Date (the “Exemption Date”) if
the market value of the Company’s Common Stock (as described below) is less than
$4.60. The number of shares issuable under the Series B Warrant on
the First Date of Determination shall be based upon the difference between $4.60
and the market value of our Common Stock (the “Initial
Issuance”). The Series B Warrant also provides for the
additional issuance of shares of Common Stock under the Series B Warrant if the
initial resale registration statement does not register all of the shares of
Common Stock underlying the Series C Preferred Stock. Such subsequent
issuance would occur on the date that is six trading days after the later of the
Effective Date or the Exemption Date (the “Second Date of
Determination”). The number of additional shares issuable
would be determined in the same manner as the Initial Issuance.
The
market value of the Common Stock shall be calculated as 82.5% of the lower of
(1) the arithmetic average of the weighted average price of the Common Stock for
each trading day during the five (5) consecutive trading days immediately
preceding the applicable date of determination, and (2) the closing bid price of
the Common Stock on the trading day immediately preceding the First Date of
Determination or the Second Date of Determination, as applicable, but will not
result in a market price lower than $4.00. If the market value of our Common
Stock is not less than $4.60 during each of two applicable pricing periods, no
shares of Common Stock would be issuable under the Series B
Warrant.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
CHINA
XD PLASTICS COMPANY LIMITED
|
|
|
|
By:
|
/s/
Jie Han |
|
|
|
Name:
|
Jie
Han |
|
|
|
Title
|
Chief
Executive Officer and Chairman |
|
|
|